Keywords: captopril, approved, post-mi, use, bristol-myers, squibb, capoten

CAPTOPRIL APPROVED FOR POST-MI USE

Article | 11 October 1993

Print This

Bristol-Myers Squibb's Capoten (captopril) has become the first ACE inhibitor to receive approval for use after a myocardial infarction in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in